Shapiro Capital Management Has Cut Its Position in Perkinelmer (PKI) by $46.16 Billion; As Alexion Pharmaceuticals (ALXN) Stock Declined, Holder Iguana Healthcare Management Cut Holding

February 15, 2018 - By Stephen Andrade

Shapiro Capital Management Llc decreased its stake in Perkinelmer Inc. (PKI) by 52.66% based on its latest 2017Q3 regulatory filing with the SEC. Shapiro Capital Management Llc sold 669,225 shares as the company’s stock rose 10.82% with the market. The institutional investor held 601,564 shares of the capital goods company at the end of 2017Q3, valued at $41.49B, down from 1.27 million at the end of the previous reported quarter. Shapiro Capital Management Llc who had been investing in Perkinelmer Inc. for a number of months, seems to be less bullish one the $8.39 billion market cap company. The stock increased 0.81% or $0.61 during the last trading session, reaching $76.07. About 147,879 shares traded. PerkinElmer, Inc. (NYSE:PKI) has risen 14.86% since February 15, 2017 and is uptrending. It has underperformed by 1.84% the S&P500.

Stuart Weisbrod decreased its stake in Alexion Pharmaceuticals Inc (ALXN) by 33.33% based on its latest 2017Q3 regulatory filing with the SEC. Iguana Healthcare Management Llc sold 20,000 shares as the company’s stock declined 11.63% while stock markets rallied. The hedge fund run by Stuart Weisbrod held 40,000 shares of the health care company at the end of 2017Q3, valued at $5.61 million, down from 60,000 at the end of the previous reported quarter. Iguana Healthcare Management Llc who had been investing in Alexion Pharmaceuticals Inc for a number of months, seems to be less bullish one the $27.48B market cap company. The stock increased 0.63% or $0.77 during the last trading session, reaching $123.97. About 921,013 shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 18.12% since February 15, 2017 and is downtrending. It has underperformed by 34.82% the S&P500.

Among 19 analysts covering PerkinElmer Inc (NYSE:PKI), 7 have Buy rating, 1 Sell and 11 Hold. Therefore 37% are positive. PerkinElmer Inc had 50 analyst reports since August 3, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Tuesday, June 20 by Jefferies. As per Thursday, September 22, the company rating was maintained by UBS. The rating was maintained by Stifel Nicolaus with “Buy” on Friday, February 5. The firm earned “Buy” rating on Thursday, October 19 by Robert W. Baird. The firm has “Neutral” rating by Cantor Fitzgerald given on Wednesday, April 19. Morgan Stanley maintained the stock with “Overweight” rating in Friday, October 6 report. The stock has “Hold” rating by Deutsche Bank on Thursday, January 7. Citigroup maintained PerkinElmer, Inc. (NYSE:PKI) on Monday, August 7 with “Buy” rating. On Tuesday, December 19 the stock rating was upgraded by Bank of America to “Neutral”. Robert W. Baird maintained it with “Outperform” rating and $78 target in Friday, November 3 report.

Since December 15, 2017, it had 0 insider buys, and 3 insider sales for $1.27 million activity.

Investors sentiment increased to 1.31 in 2017 Q3. Its up 0.12, from 1.19 in 2017Q2. It is positive, as 26 investors sold PKI shares while 93 reduced holdings. 49 funds opened positions while 107 raised stakes. 99.38 million shares or 0.76% less from 100.14 million shares in 2017Q2 were reported. Whittier Trust Of Nevada has invested 0.02% in PerkinElmer, Inc. (NYSE:PKI). Highbridge Cap Management Ltd invested in 0.01% or 4,980 shares. Amalgamated National Bank owns 21,713 shares for 0.05% of their portfolio. Tocqueville Asset Mngmt Lp holds 4,250 shares or 0% of its portfolio. 4,774 were accumulated by Liberty Mutual Asset Mngmt. 31,430 are held by Nationwide Fund Advisors. Systematic Management Ltd Partnership reported 0.36% of its portfolio in PerkinElmer, Inc. (NYSE:PKI). Bailard holds 3,069 shares or 0.02% of its portfolio. Vantage Investment Advsr Ltd Liability holds 800 shares or 0.01% of its portfolio. Ahl Partners Limited Liability Partnership holds 71,121 shares or 0.09% of its portfolio. Moreover, Neuberger Berman Gru Ltd has 0% invested in PerkinElmer, Inc. (NYSE:PKI). Alpha Windward Lc owns 0.02% invested in PerkinElmer, Inc. (NYSE:PKI) for 511 shares. Virtus Inv Advisers invested in 6,962 shares. Zurcher Kantonalbank (Zurich Cantonalbank) invested in 0% or 4,076 shares. 5,903 are owned by Public Sector Pension Inv Board.

Shapiro Capital Management Llc, which manages about $4.00 billion and $4399.01 billion US Long portfolio, upped its stake in Bwx Technologies Inc. by 200 shares to 1.96M shares, valued at $109.59B in 2017Q3, according to the filing. It also increased its holding in Axalta Coating Systems Ltd by 1.70M shares in the quarter, for a total of 2.08M shares, and has risen its stake in Ishares Iboxx Percent High Yield Corporate Bd (HYG).

Since August 28, 2017, it had 0 insider buys, and 14 insider sales for $6.68 million activity. On Monday, October 2 the insider Wagner Heidi L sold $16,800. O’Neill Julie sold $636,285 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) on Thursday, August 31. Clancy Paul J sold $707,048 worth of stock or 6,079 shares. Another trade for 1,651 shares valued at $192,028 was sold by Goff Brian. On Tuesday, February 6 Franchini Indrani Lall sold $169,696 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) or 1,459 shares. The insider HANTSON LUDWIG sold $310,521.

Among 29 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 24 have Buy rating, 0 Sell and 5 Hold. Therefore 83% are positive. Alexion Pharmaceuticals Inc. had 100 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Outperform” rating by BMO Capital Markets given on Friday, April 29. The rating was upgraded by Goldman Sachs to “Buy” on Friday, October 28. The stock has “Overweight” rating by JP Morgan on Tuesday, September 5. Credit Suisse upgraded the shares of ALXN in report on Monday, July 11 to “Outperform” rating. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has “Buy” rating given on Friday, June 23 by Stifel Nicolaus. The company was initiated on Thursday, November 3 by Deutsche Bank. The stock has “Buy” rating by SunTrust on Monday, February 12. The rating was maintained by Morgan Stanley on Friday, July 28 with “Buy”. Leerink Swann maintained Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) on Monday, September 25 with “Buy” rating. The rating was maintained by Stifel Nicolaus with “Buy” on Monday, October 23.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.